Company: GEHC
Filing Date: 2025-06-05
Form Type: 424B2
Source: 0001193125-25-135863
Chunk: 81

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-06-05
Form: 424B2
Chunk 81
---
,
New York.

EXPERTS

The financial statements of GE HealthCare Technologies Inc. as of December 31, 2023 and 2022, and for each of the three years in the
period ended December 31, 2023 incorporated by reference in this prospectus, and the effectiveness of GE HealthCare Technologies Inc.’s internal control over financial reporting as of December 31, 2023 have been audited by
Deloitte & Touche LLP, an independent registered public accounting firm, as stated in their reports. Such financial statements are incorporated by reference in reliance upon the reports of such firm given their authority as experts in
accounting and auditing.

22

$1,500,000,000

GE HealthCare Technologies Inc.

$650,000,000 4.800% Senior Notes due 2031

$850,000,000 5.500% Senior Notes due 2035

PROSPECTUS SUPPLEMENT

Joint Book-Running Managers

Citigroup

J.P. Morgan

Morgan Stanley

Barclays

### BNP PARIBAS
BofA Securities

Deutsche Bank Securities

Goldman Sachs & Co. LLC

HSBC

Mizuho

SMBC Nikko

Senior Co-Managers

ING

PNC Capital Markets LLC

Santander

SOCIETE GENERALE

Standard Chartered Bank

Co-Managers

Academy Securities

Loop Capital Markets

The date of this prospectus supplement is June 3, 2025.